Capricor Therapeutics Signs Exclusive Worldwide License Agreement with Johns Hopkins University to Expand its Exosome Platform Technology Portfolio
Stock Information for Capricor Therapeutics Inc.
Loading
Please wait while we load your information from QuoteMedia.